13/11/2024  09:16:02 Var. -0.52 Volume Denaro09:17:30 Lettera09:17:30 Capitalizzazione di mercato Dividend Y. Rapporto P/E
53.68CHF -0.96% 9,823
Fatturato: 528,286.96
53.66Quantità in denaro: 286 53.72Quantità in lettera: 517 11.17 bill.CHF 4.80% 24.52

Descrizione business

The Julius Baer Group is Switzerland’s premier private banking institution, dedicated to serving the needs of private clients, family offices, and independent asset managers globally. The company provides a comprehensive range of services, including investment advisory and discretionary mandates, structured products, securities execution and advisory, private markets and fund offerings, wealth planning, family office services, asset servicing, and Lombard lending solutions. Additionally, it offers open product platform solutions. Founded in 1890, Julius Baer Gruppe AG is headquartered in Zurich, Switzerland.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Nic Dreckmann
Consiglio di amministrazione
Evangelia Kostakis, Oliver Bartholet, Yves Bonzon, Nicolas de Skowronski, Thomas Frauenlob, Sonia Gössi, Christoph Hiestand, Jimmy Lee Kong Eng, Rahul Malhotra, Carlos Recoder Miralles, Sandra Niethen, Guido Ruoss, Luigi Vignola
Consiglio di sorveglianza
Romeo Lacher, Richard M. Campbell-Breeden, Juerg Hunziker, Kathryn Shih, Eunice Zehnder-Lai, Olga Zoutendijk, Tomas Varela Muiña, Bruce Fletcher, Andrea Sambo
 

Dati aziendali

Name: Julius Baer Gruppe AG
Indirizzo: Bahnhofstrasse 36,CH-8010 Zurich
Telefono: +41-58-888-1111
Fax: +41-58-888-1122
E-mail: -
Internet: www.juliusbaer.com
Industria: Financial
Settore: Specialty Finance
Sub settore: Diversified Financial
Fine dell'anno finanziario: 31/12
Flottante libero: 73.69%
Data dell'IPO: -

Rapporti con gli investitori

Name: Alexander van Leeuwen
IR telefono: +41-58-888-5256
IR Fax: +41-58-888-5144
IR e-mail: investor.relations@j...aer.com investor.relations@juliusbaer.com

Principali azionisti

Altri
 
74.99%
MFS Investment Management
 
9.98%
BlackRock Inc
 
5.06%
UBS Fund Management AG
 
4.99%
T. Rowe Price Associates Inc
 
4.98%